Ozempic Prior Authorization: What Plans Check and How to Get Unstuck

Ozempic prior authorization is your plan's review before it decides whether to cover your prescription. The policies below require type 2 diabetes evidence, but the rest depends on your plan, the exact product, and whether you're starting or continuing treatment. Some requests pass an automatic claim check; others need records from your prescriber.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Three things can change your answer: Medicare and Medicaid have their own rules, some plans include prior medicine use in their criteria, and plans can list Ozempic injections and tablets separately.

Below are five payer examples, the automatic checks some policies use, the deadlines that apply to different requests, and exactly what to say if you were just denied.

RX Index Decision Verdict: If you have type 2 diabetes, start with your own prescriber and the records your plan asks for.

• Best for: anyone with type 2 diabetes whose Ozempic is stuck on "prior authorization required," pending, denied, or up for renewal.
• Not ideal for: people who want Ozempic only for weight loss. Ask your clinician and plan about a medicine approved for weight loss.
• The factor that matters most: whether the request includes the diagnosis and records your plan requires.

No web page, including this one, can tell you whether you'll be approved. Your plan decides, using your records. What we can do is show you what the plan looks for, so your office can send the right records.

Start with the message you got

A prescription, an insurance approval, and a paid pharmacy claim are three different steps. The message you got from the pharmacy, the plan, or your doctor's office tells you which step is stuck. Find your message below and start there.

"PA required" is not a denial. It means the plan needs its authorization requirements met before the claim can be paid.

A quick word you'll see a lot: a pharmacy benefit manager (PBM) is the company that runs your plan's drug benefit. CVS Caremark, Express Scripts, and Optum Rx are PBMs. Check your prescription-benefit card or call its pharmacy number.

If you might run out of Ozempic before this is fixed, call your prescriber or pharmacist about a safe plan. Don't skip, stretch, or change doses on your own.

What does an Ozempic prior authorization actually check?

The Ozempic policies below require type 2 diabetes evidence, but the proof and other conditions differ. Some list a qualifying lab; others accept a documented diagnosis or ongoing-care records. These examples do not approve Ozempic for weight loss alone, and they do not all require metformin first.

Think of the rulebook as the plan's grading sheet. Your doctor fills in the request; the plan grades it against this sheet.

An A1c is a blood test that shows your average blood sugar over about three months. Step therapy is a rule that may require trying a plan-preferred medicine first.

Ozempic prior authorization rules: 5 payer examples side by side

Checked October 21, 2026. Your own plan can use a different version. Ask for the policy that applies to your exact plan and prescription.

These periods describe the published authorization terms. They do not guarantee payment, a copay, or unchanged benefits. The Blue Cross NC row is one named Medicare document, not a rule for every Blue Cross plan.

How to read it:

• Proof of type 2 diabetes is the starting point. Your plan may require more.
• Metformin is not a universal first step. In Aetna's example, it is one path of several. Ask for your plan's version.
• Weight loss alone does not meet these examples' Ozempic criteria.

Why the exact policy matters: the separate Caremark-hosted BCBSAR policy C23650-D, last reviewed March 2026, has one initial path based on metformin: at least a 90-day supply filled through a Caremark-run prescription benefit in the past 360 days, with records showing it did not work well enough. It also has alternatives, including documented intolerance or a reason metformin cannot be used. Its approval period is 1 year. That is a different policy from 5694-D above.

Want the full rules for your plan? See our guides for UnitedHealthcare, CVS Caremark, Aetna, Blue Cross, Kaiser, Cigna, Express Scripts, Optum Rx, and Humana.

Check your next step

Answer a few quick questions and you'll see what to ask, which records may be needed, the deadline rules for your type of request, and a message you can copy to your doctor's office. It doesn't predict approval. The tables and messages on this page also work without the check.

A worked example, so you don't need to click anything: Say you're 54 with type 2 diabetes. Your card says CVS Caremark. You took metformin for a year, but under your old job's plan. The pharmacy now says "PA required." Ask whether your new plan uses 5694-D and whether the pharmacy claim includes your documented diagnosis code or qualifying claim history. If a PA is needed, your office can send the diagnostic records the policy requires. That identifies the next step; it does not guarantee payment.

The automatic check: why some requests need no separate paperwork

Some policies check pharmacy claims before asking for a separate PA. CVS Caremark's 5694-D uses a diagnosis code or qualifying benefit history. UnitedHealthcare says automatic approval may depend on the program. A PBM name alone does not tell you which check applies.

Here's how the automatic check works in the rulebooks above:

• CVS Caremark 5694-D: a type 2 diabetes code submitted on the pharmacy claim can satisfy its check. Without that code, it looks back 730 days for qualifying fills under a Caremark-administered prescription benefit: at least a 30-day supply of diabetes supplies, excluding pen needles and syringes; metformin filled at least 10 days before the requested claim; or another eligible diabetes drug, excluding the policy's target GLP-1/GIP-GLP-1 drugs.
• Cigna National Formulary: ask your plan which claim check applies. The published criteria do not give a complete automatic-check rule for an adult Ozempic request.
• UnitedHealthcare: may approve from claims history and diagnosis codes. It varies by program.

Why the check can miss someone who has diabetes:

• New job or plan. Earlier fills may not appear in the current benefit's claim history.
• Cash or coupon fills. A fill paid outside insurance may be absent from that history.
• A fill that doesn't qualify. The drug, supply, or date may fall outside the policy's rules.
• No diagnosis code on the pharmacy claim. A diagnosis in your chart is not the same as one submitted with the claim.

If you have type 2 diabetes, it's fair to ask your doctor's office and pharmacist whether the documented diagnosis can be included where the plan requires it.

One line we won't blur: never ask for a diagnosis you don't have. Ask the office to send the true diagnosis and records that support it.

What to send: the Ozempic prior authorization checklist

Ask your office to match the request to your plan's rule. That may mean your type 2 diabetes diagnosis, qualifying labs or ongoing-care notes, medicine history, and the exact product and strength. Which records are needed depends on the policy and whether you're starting or continuing treatment.

You don't need to order new tests or gather all of this yourself. Ask your doctor's office which items your plan needs.

Read the broader GLP-1 document guide if you want more detail.

What if my A1c is normal now?

A lower A1c does not automatically end your coverage. CVS Caremark and Aetna accept diagnostic lab history in these policies. Your office should check which diagnosis and treatment-response records your current rule requires.

UHC also accepts chart confirmation of ongoing type 2 diabetes diagnosed more than 2 years ago. Under Aetna's continuation criteria, an A1c drop since starting is one accepted path; specified heart, kidney, or liver conditions provide other paths.

So ask the office whether to include your diagnosing lab, not just your latest one.

Does it matter whether I'm on the injection or the tablets?

Yes. Your request should name the exact product you were prescribed, and the two forms don't have identical approved uses. Plans can treat them as separate listings.

Sources: current injection prescribing information and tablet prescribing information, checked October 21, 2026. The tablet label does not include the injection's kidney indication.

The FDA approved renaming the Rybelsus R2 formulation, in 1.5, 4, and 9 mg strengths, to Ozempic tablets on January 30, 2026. Rybelsus in 3, 7, and 14 mg strengths remains listed separately. Cigna added Ozempic tablets to its Ozempic rules in May 2026.

Which form should the office use?

Use the form or online process your drug-benefit company accepts. A form you find online may belong to a different plan or program, such as a Medicare plan or TRICARE.

A message you can send your doctor's office

Copy this into your patient portal:

Hi, my Ozempic needs prior authorization from [name on my drug card]. Could you check which records my plan needs and send the request with my documented diagnosis and the required lab or treatment history? Please make sure it's for my exact product: [injection or tablets], [device, if relevant], [strength]. Does the plan need starting-treatment or continuation records? When it's sent, could you tell me the date, where it went, and the reference number? Thank you!

Asking for the date and reference number matters. That number helps you track receipt and missing records. The event that starts the decision clock depends on the request; see the deadline table below.

Who does the paperwork, and when an online clinic makes sense

Your prescriber's office supplies the clinical records and can submit the prior authorization. On Medicare, you or your prescriber can also ask your drug plan for a decision. Give the office your current plan details and ask which checklist items it needs.

If the office is slow:

• Call and ask for the status and reference number.
• Ask your pharmacy to resend the PA request to the office.
• If you're close to running out, ask your prescriber whether you meet the plan's urgent-review rules.

Here's the honest limit on online clinics: if your own doctor already prescribes your Ozempic and can handle the PA, start there. Ro would add a membership fee you don't need for that paperwork.

If you have no prescriber to handle the request, an online program may be an option. Check that it can treat your condition and work with your coverage before paying. Ro's current service limits and fees are explained below, after the cost table.

How long does Ozempic prior authorization take?

The deadline depends on your coverage and the kind of request. Novo Nordisk says an Ozempic PA can take up to 10 business days, but your plan may have a shorter legal deadline. Ask when it received the request, whether anything is missing, and when its response is due.

In the table, "pre-service" means a request for advance approval. "Expedited" means a faster review for requests that qualify.

The clock's starting point matters. For ERISA plans, a properly filed claim starts the clock even if information is missing. An allowed extension or pause has notice rules; it is not an automatic extra 15 days. Part D exceptions instead use receipt of the prescriber's supporting statement. The Medicare rows above concern drug benefits, not repayment for a drug already bought; payment requests and their first appeals generally have 14-calendar-day deadlines.

Medicaid emergency supply: federal law requires a PA system to provide for at least a 72-hour supply of a covered outpatient prescription drug in an emergency, with statutory exclusions, including drugs used for weight loss. Ask your pharmacist how the rule applies to your prescription. A pending PA alone does not guarantee an emergency fill.

California: for the commercial DMHC plans in the table, failure to notify the prescriber within the applicable deadline can mean approval for the prescription's duration, including refills. If information is missing, the plan must identify it within 72 hours, or 24 hours for exigent circumstances; the decision period begins when that information arrives. This is not a rule for every California plan.

"Urgent" is real, not a shortcut. For an ERISA job-based plan, if a doctor who knows your condition says waiting could seriously harm your health, the plan must treat the request as urgent. If you're about to run out of a diabetes medicine you're already on, tell your prescriber. The marketplace exception rule also allows expedited review for someone already receiving the nonformulary drug; its 72/24-hour limits do not apply to every marketplace PA.

Ozempic denied? Read the reason, then use the right fix

A denial letter tells you which problem to address. Missing proof, a step-therapy rule, a drug-list issue, and an excluded use need different responses. Ask which process applies: correcting a request, seeking an exception, or appealing a decision. Check the deadline before you start.

Say you're 52, on a Blue Cross plan, and just got denied. The letter says "criteria not met." Your request said "weight management," because that's what you talked about at the visit, but you also have documented type 2 diabetes. Ask the plan whether your office should correct and resubmit the request or appeal. The office should include the true diabetes diagnosis and the records that answer the stated rule.

A message you can send your plan after a denial

Please send me the written Ozempic denial, the exact coverage rule you used, and my appeal deadline. Was the problem missing records, a clinical requirement, step therapy, the drug list, or an excluded benefit? What does my prescriber need to send, and which process should we use?

How appeals work

1. Get the letter and find the deadline. Medicare gives you 65 days from the date on the initial denial notice to file your first appeal. Many private plans give you at least 180 days after you receive the denial. Check the notice for the procedure and deadline.
2. Fix what the letter names. Your prescriber's note should answer the exact rule and facts the plan used.
3. Ask whether a peer-to-peer is available. Novo Nordisk notes your doctor can request a doctor-to-doctor review with the plan.
4. Check the next review step. If the internal appeal fails, read the denial notice. Eligible private-plan disputes can go to an independent external reviewer; Medicare and Medicaid have their own appeal routes.

Do not assume a corrected request or a peer-to-peer review extends your appeal deadline. Keep the deadline in view while you fix the paperwork.

Have the written reason and the deadline? Our free GLP-1 appeal letter template helps you prepare the next request, and appeal levels explained walks through each step.

How long does an Ozempic approval last?

In the rulebooks we checked, approvals last 12 months at UnitedHealthcare, Aetna, Cigna, and the Blue Cross NC Medicare example, and 36 months under the CVS Caremark 5694-D example. A new job, new plan, or new plan year can mean a new request.

Novo Nordisk says approvals can last anywhere from 30 days to over a year, depending on your coverage. So:

• Find your approval's end date on the approval letter or in your plan's app.
• Put it on your calendar.
• Ask the plan when it accepts renewal requests, then ask the office to submit within that window.

Renewals can use different rules than first requests. Aetna's continuation path requires at least 3 months on a stable maintenance dose of a GLP-1 or GIP/GLP-1 medicine. An A1c drop is one accepted response path; specified cardiovascular, kidney, or liver conditions are alternatives. A refill alone does not establish which criteria apply. See initial requests vs. renewals.

Can you get Ozempic prior authorization for weight loss?

Weight loss alone does not meet the Ozempic policies we checked. Ozempic's approved uses require type 2 diabetes. If weight loss is your goal, ask your clinician and plan about an appropriate weight-management medicine, such as Wegovy, Zepbound, or Foundayo, and its own coverage rules.

Cigna's Ozempic policies list weight loss alone as not covered. The other examples above also require a type 2 diabetes indication or diagnosis. That is why the reason for the prescription matters.

Prediabetes alone does not meet these examples' type 2 diabetes requirement. Cigna's policies list it as not covered for Ozempic. More on that in Ozempic and prediabetes.

For adults, a clinician may consider weight-management medicine at a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure. That is a starting point for a medical review, not proof that a drug fits you or your plan will pay. The benefit has its own rules and required records. Our GLP-1 prior authorization requirements by insurer dataset shows published examples, and Ozempic vs. Wegovy explains why these semaglutide brands have different approved uses and coverage rules.

Part D excludes drugs when used solely for weight loss, but may cover a GLP-1 for another covered indication. Separately, the Medicare GLP-1 Bridge offers eligible members Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen only for a $50 monthly copay from July 1, 2026, through December 31, 2027. Ozempic is not on its drug list. Medicare also says people with type 2 diabetes are not eligible for the Bridge and should check Part D coverage. See the Medicare GLP-1 Bridge guide.

What it costs while you wait (and after approval)

Approval does not set your final price: you may owe a deductible, copay, or coinsurance. Eligible patients with commercial Ozempic coverage may pay as little as $25 with the savings offer. Its introductory self-pay pen price is $199 for each of the first two eligible fills; standard pen prices are $349 or $499, depending on strength.

These are the retail Ozempic Savings Offer terms, checked October 21, 2026. Each offer requires a prescription for an FDA-approved Ozempic use and meeting its full eligibility terms.

For this savings offer, FEHB, ACA Marketplace, and state-employee insurance plans are not classified as government coverage. The other eligibility rules still apply.

Before counting on the $25 offer, ask your plan whether it uses a copay "accumulator" or "maximizer." These programs change how manufacturer savings affect your costs; NovoCare's terms exclude patients in them.

Three money details people miss:

1. An offer's "month" is not a calendar-month estimate. The introductory pen offer covers 28-day fills; the standard pen table prices one box containing one pen. Tablet bottles represent 30 days.
2. This self-pay offer does not count toward your deductible or out-of-pocket limit. You cannot submit these purchases for insurance reimbursement.
3. Fills outside insurance may not appear in the claim history used for an automatic check. Ask your pharmacy or prescriber for treatment records if the plan needs them.

On Medicare, you can't use the $25 commercial-insurance card. The terms do let eligible government-insured patients use the self-pay offer, but that spending won't count toward Part D costs. More in the Ozempic savings card guide and Ozempic cost with insurance.

If you need an online clinic to handle a new request

Ro's paid membership includes insurance support after a Ro-affiliated provider prescribes. Its free coverage report is a separate step: it reports coverage information and does not submit a treatment request. Neither service guarantees approval.

An online program can make sense if you have job-based or marketplace insurance and no prescriber who'll do the paperwork. Ro's insurance team checks your coverage. Then, if a Ro-affiliated provider prescribes, the team submits the prior authorization and handles the back-and-forth with your plan. Ro estimates 1 to 3 weeks for that coordination after a prescription; this is its service estimate, not a legal decision deadline. If Ozempic isn't the right fit or isn't covered, Ro's clinicians can suggest other FDA-approved options.

What it costs, from Ro's pricing page on October 21, 2026: $39 for the first month, refunded if you're not eligible for GLP-1 treatment. After that, the annual plan is $74/month as an equivalent price, paid as $888 upfront (12 × $74), separate from the introductory month. Shorter prepaid plans cost more per month; the monthly plan is $149. Membership includes provider support, insurance coordination, and lab testing if needed. Medication costs extra, based on your prescription and coverage or cash-pay option.

Ro offers insurance help for commercial and FEHB plans. Its FAQ says people with Medicare, a Medicare supplement plan, or TRICARE may qualify for certain cash-pay treatment options. Medicaid members and people with some other government-funded plans are currently ineligible for treatment on Ro.

Ro's free coverage checker asks for insurance details and sends an emailed report. Its listed scope is the Ozempic pen, Wegovy pen, and Zepbound pen; Ozempic tablets are not listed. Ro contacts your insurer for coverage information but does not submit a treatment request or write a prescription through this free check.

If you'd rather compare first, see how Ro handles GLP-1 prior authorization and other providers that help with prior authorization.

Medicare and Medicaid follow different rules

Medicare Part D may cover Ozempic for type 2 diabetes, subject to your plan's rules. Standard drug-benefit decisions generally use a 72-hour deadline, or 24 hours if expedited; exceptions have a different starting point. Medicaid covered outpatient-drug PA systems must respond within 24 hours and provide an emergency-supply process within the limits above.

Medicare: The Blue Cross NC example above uses an FDA-labeled indication plus its treatment-history or other listed criteria. Recent use is one path through the PA, not a blanket exemption from it. Its stated approval period is 12 months. You, your representative, or your prescriber can ask the plan for a "coverage determination," which is Medicare's name for the decision. See does Medicare cover Ozempic.

Medicaid: Start with your state's preferred drug list and your managed-care plan, if you have one. Ask for the current Ozempic criteria and which records your prescriber must send. Check your state in our GLP-1 Medicaid coverage tracker.

TRICARE and VA have their own processes: see TRICARE and Ozempic and VA GLP-1 coverage.

What we actually verified

On October 21, 2026, we read these documents at the source:

• Payer rulebooks: CVS Caremark 5694-D (P05-2025) and the separate BCBSAR C23650-D example (last reviewed March 2026); Aetna 2439-C and its matching Caremark PDF (Aetna page dated March 18, 2026); Cigna IP0701 (effective June 15, 2026) and CNF360 (reviewed June 3, 2026); UnitedHealthcare 2026 P 1332-8 (effective July 1, 2026); the Ozempic injection section of Blue Cross NC's 2026 Enhanced NCSC Medicare criteria (updated September 2026).
• Deadline rules: CMS coverage-decision and exception guidance; Medicare.gov appeals; the federal ERISA claims rule; HealthCare.gov internal and external appeals; 45 CFR 156.122(c); the federal Medicaid drug-PA and managed-care appeal rules; and DMHC's June 2026 prescription-drug guide.
• Prices and terms: NovoCare's full retail Ozempic Savings Offer terms; Ro's pricing, insurance FAQ, and GLP-1 insurance checker pages.
• Drug uses and programs: FDA Ozempic injection and tablet labels, current manufacturer prescribing information, the FDA's January 30, 2026 tablet-name approval letter, and Medicare.gov/CMS Bridge guidance.

Provider-stated, not tested by us: Ro's 1-to-3-week insurance timeline and how its team handles requests. We didn't submit a request or run a patient coverage check.

What we couldn't confirm: your employer's custom version of any rule, your own benefits, and your chances of approval or a successful appeal. We did not establish a reliable Ozempic-specific approval or appeal-success rate, so we don't print one. Read how we evaluate.

Frequently asked questions

Does Ozempic require prior authorization?

Your plan's drug list and rules determine whether it requires PA. A separate request is not always needed: the checked Caremark policy has an automatic claim check, and UHC says automatic approval varies by program. If your pharmacy says "PA required," ask your office whether a request has been sent.

Why do I need a PA if my plan covers Ozempic?

Being on the drug list doesn't mean "no strings attached." A plan can list Ozempic as covered with prior authorization, meaning the request must meet its coverage criteria. The examples above require type 2 diabetes evidence. Ask your office whether the request has been sent.

How long does Ozempic prior authorization take?

Novo Nordisk says up to 10 business days. Standard Medicare Part D drug-benefit requests generally use 72 hours, or 24 hours if expedited. ERISA pre-service requests generally use 15 days, with limited extensions. The clock starts differently: Part D exceptions use receipt of the prescriber's supporting statement; a properly filed ERISA claim starts the clock even if information is missing.

Why does my refill need a new prior authorization?

Your approval may have ended, or your plan or its rules may have changed with a new job or plan year. The policies we checked state approval periods of 12 to 36 months. Ask the plan for your end date and when it accepts a renewal request.

Can you get Ozempic prior authorization for weight loss?

Weight loss alone does not meet the Ozempic policies we checked. Their Ozempic criteria require type 2 diabetes evidence. Ask your clinician and your plan about an appropriate weight-management medicine, such as Wegovy, Zepbound, or Foundayo, and its own rules.

What A1c do you need for Ozempic prior authorization?

UnitedHealthcare, CVS Caremark, and Aetna list an A1c of 6.5% or higher among their diabetes-evidence options, alongside qualifying glucose tests. That number alone does not establish approval. The policy may require other records or conditions; ask which rule applies to you.

Do I have to try metformin first?

The checked UnitedHealthcare, Cigna, and CVS Caremark 5694-D provisions do not require a metformin trial. Aetna lists it as one of several starting-treatment paths, not a universal requirement. The separate BCBSAR example includes a 90-day trial as one path. Ask for your plan's exact policy before assuming those examples apply.

My A1c is normal now. Will I lose coverage?

Not automatically. Caremark and Aetna use diagnostic lab history in the checked policies. UHC has an ongoing-care chart pathway for type 2 diabetes diagnosed more than 2 years ago. An A1c drop is one of Aetna's continuation paths. Ask your office which records your current rule needs.

Does Medicare require prior authorization for Ozempic?

Check your Part D plan's drug list and PA rules. The BCNC example above requires PA; the Bridge does not include Ozempic. You or your prescriber can request a coverage decision. Standard drug-benefit requests generally use 72 hours, or 24 hours if expedited; for an exception, the clock starts when the prescriber's supporting statement arrives.

Is the Ozempic pill under the same prior authorization?

Some policies, including the checked Cigna provisions, address both. Your plan can still list injections and tablets separately, and their approved uses differ: tablets do not have the injection's kidney indication. Ask about your exact form and strength by name.

Why is my price still high after approval?

PA approval clears that requirement; the pharmacy claim still has to meet the rest of your plan's rules. You may owe a deductible, coinsurance, or a high-tier copay. Ask the pharmacist for the claim breakdown, and if you have commercial insurance, check whether the $25 savings card applies.

Sources

All checked October 21, 2026. Dates below identify the source version, policy date, or approval event where stated.

• CVS Caremark 5694-D, Antidiabetic GLP-1 PA with logic (P05-2025)
• Caremark-hosted BCBSAR C23650-D (last reviewed March 2026)
• Aetna 2439-C (page dated March 18, 2026) and matching Caremark 2439-C PDF
• Cigna IP0701, specified employer drug lists (effective June 15, 2026)
• Cigna CNF360, National Formulary GLP-1 PA (reviewed June 3, 2026)
• UnitedHealthcare 2026 P 1332-8 (effective July 1, 2026)
• Blue Cross NC 2026 Enhanced NCSC Medicare criteria, Ozempic injection, printed page 191 (updated September 2026)
• NovoCare, Ozempic coverage and prior authorization
• NovoCare, retail Ozempic Savings Offer terms and self-pay prices
• FDA Ozempic injection label and current manufacturer injection prescribing information
• FDA Ozempic/Rybelsus tablet label, current tablet prescribing information, and FDA name-change approval letter (January 30, 2026)
• Wegovy prescribing information, Zepbound prescribing information, and FDA Foundayo label
• NIDDK, the A1c test and prescription medicines for overweight and obesity
• CMS, Medicare Part D coverage determinations and exceptions
• Medicare.gov, appeals in a Medicare drug plan
• 29 CFR 2560.503-1, ERISA claims procedure
• HealthCare.gov, internal appeals and external review
• 45 CFR 156.122, prescription-drug exception rules
• Social Security Act §1927(d)(5), Medicaid drug prior authorization and 42 CFR 438.408, Medicaid managed-care appeals
• California DMHC, prescription-drug technical assistance guide (June 2, 2026), including Health and Safety Code §1367.241
• Medicare.gov, Bridge drug list and eligibility and CMS, Medicare GLP-1 Bridge dates and program structure
• Ro, weight-loss pricing, GLP-1 insurance checker, and insurance support and eligibility